PEMAZYRE
Live / Registered — Registered (as of 21 Sept 2021)
What this means for you
Registered since 21 Sept 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88616570
- Registration number
- 6494001
- Mark type
- Design + words
- Filed
- 13 Sept 2019
- Published for opposition
- 16 Jun 2020
- Registered
- 21 Sept 2021
- Attorney of record
- Frances M. Jagla
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of immunological disorders; pharmaceutical preparations for the treatment of hematological disorders; pharmaceutical preparations for the treatment of hypophosphatemia disorders; pharmaceutical preparations for the treatment of myeloproliferative disorders; pharmaceutical preparations for the treatment of skeletal or chondrocyte disorders
Owner
- INCYTE HOLDINGS CORPORATION, Wilmington, DE, US
- INCYTE HOLDINGS CORPORATION, Wilmington, DE, US
- INCYTE HOLDINGS CORPORATION, Wilmington, DE, US
Prosecution history
- 21 Sept 2021 — REGISTERED-PRINCIPAL REGISTER
- 20 Aug 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 19 Aug 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 05 Aug 2021 — SOU TEAS EXTENSION RECEIVED
- 20 Jul 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 07 Jul 2021 — USE AMENDMENT FILED
- 16 Jul 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 07 Jul 2021 — TEAS STATEMENT OF USE RECEIVED
- 05 Feb 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Feb 2021 — SOU EXTENSION 1 GRANTED
- 03 Feb 2021 — SOU EXTENSION 1 FILED
- 03 Feb 2021 — SOU TEAS EXTENSION RECEIVED
- 11 Aug 2020 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 16 Jun 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Jun 2020 — PUBLISHED FOR OPPOSITION